8-KThe WireStrategic
Results of Operations
Filed Feb 1, 2024 · 2y ago · Accession 0000950170-24-009852
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Feb 1, 2024
- Report date
- Feb 1, 2024
- Document
- abio-20240201.htm
- Size
- 247 KB